Global Cellular Health Testing Market to Reach $5.8 Billion by 2030

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

| Source: ReportLinker ReportLinker

New York, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Cellular Health Testing Industry" - https://www.reportlinker.com/p05956260/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Cellular Health Testing Market to Reach $5.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Cellular Health Testing estimated at US$3 Billion in the year 2022, is projected to reach a revised size of US$5.8 Billion by 2030, growing at aCAGR of 8.6% over the period 2022-2030. Single-Test Panels, one of the segments analyzed in the report, is projected to record 7.4% CAGR and reach US$3.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Multi-Test Panels segment is readjusted to a revised 10.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $880.9 Million, While China is Forecast to Grow at 8.1% CAGR

The Cellular Health Testing market in the U.S. is estimated at US$880.9 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2030 trailing a CAGR of 8.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.7% and 7.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.

Select Competitors (Total 22 Featured)
- Bio-Reference Laboratories, Inc.
- Cell Science Systems Corp.
- Cleveland Heartlab, Inc.
- Dna Labs India
- Genova Diagnostics
- Immundiagnostik AG
- Laboratory Corporation of America Holdings
- Life Length
- Quest Diagnostics, Inc.
- Repeat Diagnostics Inc. (Repeat Dx)
- Segterra, Inc.
- SpectraCell Laboratories, Inc.
- Telomere Diagnostics, Inc. (Tdx)
- Zimetry LLC


Read the full report: https://www.reportlinker.com/p05956260/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Cellular Health Testing - Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Cellular Health Testing - Revolutionary Technology Provides
Overview of Health at Cellular Level
North America Projected to Retain Maximum Share in the Market

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Rising Demand for Accurate Telomere Length Test Steers Market
Growth
Digital Transformation in Healthcare to Offer Significant
Market Gains
Focus on Healthy Life Expectancy (HLE) as a Measure of
Population Health Promise Growth Opportunities
Cellular Approach to Tackle Chronic Diseases Ensure Steady
Growth Prospects
Continuous Rise in Geriatric Population Throws Focus on
Cellular Heath Screening
Percentage (In %) of Global Population Aged 65 and Above by Region
US Population (In Million) Aged 65 and Above for the Years
2018, 2021, 2024, 2027, and 2030
Government Policies and Measures Promoting Preventative
Healthcare Augurs Well
Personalized and Precision Medicine Presents Application
Opportunities for Cellular Health Screening
Global Precision Medicine Market (In US$ Billion) for the Years
2019, 2021, 2023, 2025 & 2027
Growing Popularity of Direct-To-Consumer Approach to Testing
Drives Market Demand
Key Challenges
Limited Reimbursement
Challenges in Sample Transportation
Variation in Pricing of Test Kits
Covid-19 Impact on Cellular Health Testing Market

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Cellular Health Testing by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 2: World Historic Review for Cellular Health Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 3: World 16-Year Perspective for Cellular Health Testing
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Single-test Panels by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 5: World Historic Review for Single-test Panels by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 6: World 16-Year Perspective for Single-test Panels by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Multi-test Panels by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 8: World Historic Review for Multi-test Panels by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 9: World 16-Year Perspective for Multi-test Panels by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Blood Samples by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 11: World Historic Review for Blood Samples by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 12: World 16-Year Perspective for Blood Samples by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
At-home by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 14: World Historic Review for At-home by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 15: World 16-Year Perspective for At-home by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
In-office by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 17: World Historic Review for In-office by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 18: World 16-Year Perspective for In-office by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 19: World Cellular Health Testing Market Analysis of
Annual Sales in US$ Million for Years 2014 through 2030

Table 20: World Recent Past, Current & Future Analysis for
Other Sample Types by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 21: World Historic Review for Other Sample Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 22: World 16-Year Perspective for Other Sample Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 23: World Recent Past, Current & Future Analysis for
Other Collection Sites by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 24: World Historic Review for Other Collection Sites by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 25: World 16-Year Perspective for Other Collection Sites
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES
Cellular Health Testing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2023 (E)
Table 26: USA Recent Past, Current & Future Analysis for
Cellular Health Testing by Type - Single-test Panels and
Multi-test Panels - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 27: USA Historic Review for Cellular Health Testing by
Type - Single-test Panels and Multi-test Panels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 28: USA 16-Year Perspective for Cellular Health Testing
by Type - Percentage Breakdown of Value Sales for Single-test
Panels and Multi-test Panels for the Years 2014, 2023 & 2030

Table 29: USA Recent Past, Current & Future Analysis for
Cellular Health Testing by Sample Type - Blood Samples and
Other Sample Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 30: USA Historic Review for Cellular Health Testing by
Sample Type - Blood Samples and Other Sample Types Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 31: USA 16-Year Perspective for Cellular Health Testing
by Sample Type - Percentage Breakdown of Value Sales for Blood
Samples and Other Sample Types for the Years 2014, 2023 & 2030

Table 32: USA Recent Past, Current & Future Analysis for
Cellular Health Testing by Collection Site - At-home, In-office
and Other Collection Sites - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 33: USA Historic Review for Cellular Health Testing by
Collection Site - At-home, In-office and Other Collection Sites
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 34: USA 16-Year Perspective for Cellular Health Testing
by Collection Site - Percentage Breakdown of Value Sales for
At-home, In-office and Other Collection Sites for the Years
2014, 2023 & 2030

CANADA
Table 35: Canada Recent Past, Current & Future Analysis for
Cellular Health Testing by Type - Single-test Panels and
Multi-test Panels - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 36: Canada Historic Review for Cellular Health Testing by
Type - Single-test Panels and Multi-test Panels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 37: Canada 16-Year Perspective for Cellular Health
Testing by Type - Percentage Breakdown of Value Sales for
Single-test Panels and Multi-test Panels for the Years 2014,
2023 & 2030

Table 38: Canada Recent Past, Current & Future Analysis for
Cellular Health Testing by Sample Type - Blood Samples and
Other Sample Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 39: Canada Historic Review for Cellular Health Testing by
Sample Type - Blood Samples and Other Sample Types Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 40: Canada 16-Year Perspective for Cellular Health
Testing by Sample Type - Percentage Breakdown of Value Sales
for Blood Samples and Other Sample Types for the Years 2014,
2023 & 2030

Table 41: Canada Recent Past, Current & Future Analysis for
Cellular Health Testing by Collection Site - At-home, In-office
and Other Collection Sites - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 42: Canada Historic Review for Cellular Health Testing by
Collection Site - At-home, In-office and Other Collection Sites
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 43: Canada 16-Year Perspective for Cellular Health
Testing by Collection Site - Percentage Breakdown of Value
Sales for At-home, In-office and Other Collection Sites for the
Years 2014, 2023 & 2030

JAPAN
Cellular Health Testing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2023 (E)
Table 44: Japan Recent Past, Current & Future Analysis for
Cellular Health Testing by Type - Single-test Panels and
Multi-test Panels - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 45: Japan Historic Review for Cellular Health Testing by
Type - Single-test Panels and Multi-test Panels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 46: Japan 16-Year Perspective for Cellular Health Testing
by Type - Percentage Breakdown of Value Sales for Single-test
Panels and Multi-test Panels for the Years 2014, 2023 & 2030

Table 47: Japan Recent Past, Current & Future Analysis for
Cellular Health Testing by Sample Type - Blood Samples and
Other Sample Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 48: Japan Historic Review for Cellular Health Testing by
Sample Type - Blood Samples and Other Sample Types Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 49: Japan 16-Year Perspective for Cellular Health Testing
by Sample Type - Percentage Breakdown of Value Sales for Blood
Samples and Other Sample Types for the Years 2014, 2023 & 2030

Table 50: Japan Recent Past, Current & Future Analysis for
Cellular Health Testing by Collection Site - At-home, In-office
and Other Collection Sites - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 51: Japan Historic Review for Cellular Health Testing by
Collection Site - At-home, In-office and Other Collection Sites
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 52: Japan 16-Year Perspective for Cellular Health Testing
by Collection Site - Percentage Breakdown of Value Sales for
At-home, In-office and Other Collection Sites for the Years
2014, 2023 & 2030

CHINA
Cellular Health Testing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2023 (E)
Table 53: China Recent Past, Current & Future Analysis for
Cellular Health Testing by Type - Single-test Panels and
Multi-test Panels - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 54: China Historic Review for Cellular Health Testing by
Type - Single-test Panels and Multi-test Panels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 55: China 16-Year Perspective for Cellular Health Testing
by Type - Percentage Breakdown of Value Sales for Single-test
Panels and Multi-test Panels for the Years 2014, 2023 & 2030

Table 56: China Recent Past, Current & Future Analysis for
Cellular Health Testing by Sample Type - Blood Samples and
Other Sample Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 57: China Historic Review for Cellular Health Testing by
Sample Type - Blood Samples and Other Sample Types Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 58: China 16-Year Perspective for Cellular Health Testing
by Sample Type - Percentage Breakdown of Value Sales for Blood
Samples and Other Sample Types for the Years 2014, 2023 & 2030

Table 59: China Recent Past, Current & Future Analysis for
Cellular Health Testing by Collection Site - At-home, In-office
and Other Collection Sites - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 60: China Historic Review for Cellular Health Testing by
Collection Site - At-home, In-office and Other Collection Sites
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 61: China 16-Year Perspective for Cellular Health Testing
by Collection Site - Percentage Breakdown of Value Sales for
At-home, In-office and Other Collection Sites for the Years
2014, 2023 & 2030

EUROPE
Cellular Health Testing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2023 (E)
Table 62: Europe Recent Past, Current & Future Analysis for
Cellular Health Testing by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2022 through 2030 and %
CAGR

Table 63: Europe Historic Review for Cellular Health Testing by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 64: Europe 16-Year Perspective for Cellular Health
Testing by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2014, 2023 & 2030

Table 65: Europe Recent Past, Current & Future Analysis for
Cellular Health Testing by Type - Single-test Panels and
Multi-test Panels - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 66: Europe Historic Review for Cellular Health Testing by
Type - Single-test Panels and Multi-test Panels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 67: Europe 16-Year Perspective for Cellular Health
Testing by Type - Percentage Breakdown of Value Sales for
Single-test Panels and Multi-test Panels for the Years 2014,
2023 & 2030

Table 68: Europe Recent Past, Current & Future Analysis for
Cellular Health Testing by Sample Type - Blood Samples and
Other Sample Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 69: Europe Historic Review for Cellular Health Testing by
Sample Type - Blood Samples and Other Sample Types Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 70: Europe 16-Year Perspective for Cellular Health
Testing by Sample Type - Percentage Breakdown of Value Sales
for Blood Samples and Other Sample Types for the Years 2014,
2023 & 2030

Table 71: Europe Recent Past, Current & Future Analysis for
Cellular Health Testing by Collection Site - At-home, In-office
and Other Collection Sites - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 72: Europe Historic Review for Cellular Health Testing by
Collection Site - At-home, In-office and Other Collection Sites
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 73: Europe 16-Year Perspective for Cellular Health
Testing by Collection Site - Percentage Breakdown of Value
Sales for At-home, In-office and Other Collection Sites for the
Years 2014, 2023 & 2030

FRANCE
Cellular Health Testing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2023 (E)
Table 74: France Recent Past, Current & Future Analysis for
Cellular Health Testing by Type - Single-test Panels and
Multi-test Panels - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 75: France Historic Review for Cellular Health Testing by
Type - Single-test Panels and Multi-test Panels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 76: France 16-Year Perspective for Cellular Health
Testing by Type - Percentage Breakdown of Value Sales for
Single-test Panels and Multi-test Panels for the Years 2014,
2023 & 2030

Table 77: France Recent Past, Current & Future Analysis for
Cellular Health Testing by Sample Type - Blood Samples and
Other Sample Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 78: France Historic Review for Cellular Health Testing by
Sample Type - Blood Samples and Other Sample Types Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 79: France 16-Year Perspective for Cellular Health
Testing by Sample Type - Percentage Breakdown of Value Sales
for Blood Samples and Other Sample Types for the Years 2014,
2023 & 2030

Table 80: France Recent Past, Current & Future Analysis for
Cellular Health Testing by Collection Site - At-home, In-office
and Other Collection Sites - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 81: France Historic Review for Cellular Health Testing by
Collection Site - At-home, In-office and Other Collection Sites
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 82: France 16-Year Perspective for Cellular Health
Testing by Collection Site - Percentage Breakdown of Value
Sales for At-home, In-office and Other Collection Sites for the
Years 2014, 2023 & 2030

GERMANY
Cellular Health Testing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2023 (E)
Table 83: Germany Recent Past, Current & Future Analysis for
Cellular Health Testing by Type - Single-test Panels and
Multi-test Panels - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 84: Germany Historic Review for Cellular Health Testing
by Type - Single-test Panels and Multi-test Panels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 85: Germany 16-Year Perspective for Cellular Health
Testing by Type - Percentage Breakdown of Value Sales for
Single-test Panels and Multi-test Panels for the Years 2014,
2023 & 2030

Table 86: Germany Recent Past, Current & Future Analysis for
Cellular Health Testing by Sample Type - Blood Samples and
Other Sample Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 87: Germany Historic Review for Cellular Health Testing
by Sample Type - Blood Samples and Other Sample Types Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 88: Germany 16-Year Perspective for Cellular Health
Testing by Sample Type - Percentage Breakdown of Value Sales
for Blood Samples and Other Sample Types for the Years 2014,
2023 & 2030

Table 89: Germany Recent Past, Current & Future Analysis for
Cellular Health Testing by Collection Site - At-home, In-office
and Other Collection Sites - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 90: Germany Historic Review for Cellular Health Testing
by Collection Site - At-home, In-office and Other Collection
Sites Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 91: Germany 16-Year Perspective for Cellular Health
Testing by Collection Site - Percentage Breakdown of Value
Sales for At-home, In-office and Other Collection Sites for the
Years 2014, 2023 & 2030

ITALY
Table 92: Italy Recent Past, Current & Future Analysis for
Cellular Health Testing by Type - Single-test Panels and
Multi-test Panels - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 93: Italy Historic Review for Cellular Health Testing by
Type - Single-test Panels and Multi-test Panels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 94: Italy 16-Year Perspective for Cellular Health Testing
by Type - Percentage Breakdown of Value Sales for Single-test
Panels and Multi-test Panels for the Years 2014, 2023 & 2030

Table 95: Italy Recent Past, Current & Future Analysis for
Cellular Health Testing by Sample Type - Blood Samples and
Other Sample Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 96: Italy Historic Review for Cellular Health Testing by
Sample Type - Blood Samples and Other Sample Types Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 97: Italy 16-Year Perspective for Cellular Health Testing
by Sample Type - Percentage Breakdown of Value Sales for Blood
Samples and Other Sample Types for the Years 2014, 2023 & 2030

Table 98: Italy Recent Past, Current & Future Analysis for
Cellular Health Testing by Collection Site - At-home, In-office
and Other Collection Sites - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 99: Italy Historic Review for Cellular Health Testing by
Collection Site - At-home, In-office and Other Collection Sites
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 100: Italy 16-Year Perspective for Cellular Health
Testing by Collection Site - Percentage Breakdown of Value
Sales for At-home, In-office and Other Collection Sites for the
Years 2014, 2023 & 2030

UNITED KINGDOM
Cellular Health Testing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 101: UK Recent Past, Current & Future Analysis for
Cellular Health Testing by Type - Single-test Panels and
Multi-test Panels - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 102: UK Historic Review for Cellular Health Testing by
Type - Single-test Panels and Multi-test Panels Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 103: UK 16-Year Perspective for Cellular Health Testing
by Type - Percentage Breakdown of Value Sales for Single-test
Panels and Multi-test Panels for the Years 2014, 2023 & 2030

Table 104: UK Recent Past, Current & Future Analysis for
Cellular Health Testing by Sample Type - Blood Samples and
Other Sample Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 105: UK Historic Review for Cellular Health Testing by
Sample Type - Blood Samples and Other Sample Types Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 106: UK 16-Year Perspective for Cellular Health Testing
by Sample Type - Percentage Breakdown of Value Sales for Blood
Samples and Other Sample Types for the Years 2014, 2023 & 2030

Table 107: UK Recent Past, Current & Future Analysis for
Cellular Health Testing by Collection Site - At-home, In-office
and Other Collection Sites - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 108: UK Historic Review for Cellular Health Testing by
Collection Site - At-home, In-office and Other Collection Sites
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 109: UK 16-Year Perspective for Cellular Health Testing
by Collection Site - Percentage Breakdown of Value Sales for
At-home, In-office and Other Collection Sites for the Years
2014, 2023 & 2030

REST OF EUROPE
Table 110: Rest of Europe Recent Past, Current & Future
Analysis for Cellular Health Testing by Type - Single-test
Panels and Multi-test Panels - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 111: Rest of Europe Historic Review for Cellular Health
Testing by Type - Single-test Panels and Multi-test Panels
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 112: Rest of Europe 16-Year Perspective for Cellular
Health Testing by Type - Percentage Breakdown of Value Sales
for Single-test Panels and Multi-test Panels for the Years
2014, 2023 & 2030

Table 113: Rest of Europe Recent Past, Current & Future
Analysis for Cellular Health Testing by Sample Type - Blood
Samples and Other Sample Types - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 114: Rest of Europe Historic Review for Cellular Health
Testing by Sample Type - Blood Samples and Other Sample Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 115: Rest of Europe 16-Year Perspective for Cellular
Health Testing by Sample Type - Percentage Breakdown of Value
Sales for Blood Samples and Other Sample Types for the Years
2014, 2023 & 2030

Table 116: Rest of Europe Recent Past, Current & Future
Analysis for Cellular Health Testing by Collection Site -
At-home, In-office and Other Collection Sites - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 117: Rest of Europe Historic Review for Cellular Health
Testing by Collection Site - At-home, In-office and Other
Collection Sites Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2014 through 2021 and % CAGR

Table 118: Rest of Europe 16-Year Perspective for Cellular
Health Testing by Collection Site - Percentage Breakdown of
Value Sales for At-home, In-office and Other Collection Sites
for the Years 2014, 2023 & 2030

ASIA-PACIFIC
Cellular Health Testing Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 119: Asia-Pacific Recent Past, Current & Future Analysis
for Cellular Health Testing by Type - Single-test Panels and
Multi-test Panels - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 120: Asia-Pacific Historic Review for Cellular Health
Testing by Type - Single-test Panels and Multi-test Panels
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 121: Asia-Pacific 16-Year Perspective for Cellular Health
Testing by Type - Percentage Breakdown of Value Sales for
Single-test Panels and Multi-test Panels for the Years 2014,
2023 & 2030

Table 122: Asia-Pacific Recent Past, Current & Future Analysis
for Cellular Health Testing by Sample Type - Blood Samples and
Other Sample Types - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 123: Asia-Pacific Historic Review for Cellular Health
Testing by Sample Type - Blood Samples and Other Sample Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 124: Asia-Pacific 16-Year Perspective for Cellular Health
Testing by Sample Type - Percentage Breakdown of Value Sales
for Blood Samples and Other Sample Types for the Years 2014,
2023 & 2030

Table 125: Asia-Pacific Recent Past, Current & Future Analysis
for Cellular Health Testing by Collection Site - At-home,
In-office and Other Collection Sites - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 126: Asia-Pacific Historic Review for Cellular Health
Testing by Collection Site - At-home, In-office and Other
Collection Sites Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2014 through 2021 and % CAGR

Table 127: Asia-Pacific 16-Year Perspective for Cellular Health
Testing by Collection Site - Percentage Breakdown of Value
Sales for At-home, In-office and Other Collection Sites for the
Years 2014, 2023 & 2030

REST OF WORLD
Table 128: Rest of World Recent Past, Current & Future Analysis
for Cellular Health Testing by Type - Single-test Panels and
Multi-test Panels - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 129: Rest of World Historic Review for Cellular Health
Testing by Type - Single-test Panels and Multi-test Panels
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 130: Rest of World 16-Year Perspective for Cellular

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05956260/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

 

            











    

        

        
Contact Data